Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line. Gu X, Huang Z, Chen J, Luo Y, et al. Invest Ophthalmol Vis Sci 2023;64:16.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gu X, Huang Z, Chen J, Luo Y, et al. Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line. Invest Ophthalmol Vis Sci 2023;64:16.
PMID: 38095907